Edition:
India

Biostar Pharmaceuticals Inc (BSPM.OQ)

BSPM.OQ on NASDAQ Stock Exchange Capital Market

1.81USD
24 Nov 2017
Change (% chg)

$-0.01 (-0.55%)
Prev Close
$1.82
Open
$1.80
Day's High
$1.90
Day's Low
$1.75
Volume
7,215
Avg. Vol
22,537
52-wk High
$4.29
52-wk Low
$1.18

Latest Key Developments (Source: Significant Developments)

Biostar Pharma qtrly ‍loss per share $0.05
Tuesday, 21 Nov 2017 

Nov 20 (Reuters) - Biostar Pharmaceuticals Inc ::Biostar Pharmaceuticals Inc. announces its quarterly results for nine months ended September 30, 2017.Biostar Pharmaceuticals Inc - qtrly ‍loss per share $0.05.  Full Article

Biostar Pharmaceuticals qtrly loss per share $‍0.50​
Thursday, 16 Nov 2017 

Nov 15 (Reuters) - Biostar Pharmaceuticals Inc :Biostar Pharmaceuticals, Inc. announces its quarterly results for three months ended June 30, 2017.Biostar Pharmaceuticals Inc - ‍during fiscal Q2 of 2017 company recognized no net sales​.Biostar Pharmaceuticals Inc qtrly loss per share $‍0.50​.  Full Article

Biostar Pharmaceuticals signs a letter of intent to acquire Xianyang Yongsheng Health Products Co Ltd
Thursday, 22 Sep 2016 

Biostar Pharmaceuticals Inc : Biostar Pharmaceuticals signs a letter of intent to acquire Xianyang Yongsheng Health Products Co Ltd . To buy 100% of equity interest in Xianyang Yongsheng in exchange for cash payment, issuance of shares of Biostar's restricted common stock .Companies seek to complete this transaction in second half of 2016.  Full Article

Biostar Pharmaceuticals reports qtrly loss per share $3.12
Tuesday, 23 Aug 2016 

Biostar Pharmaceuticals Inc : Announces its quarterly results for three months ended June 30, 2016 . Fiscal Q2 net sales of $0.6 million, a decrease of approximately $13.6 million .Qtrly loss per share $3.12.  Full Article

Biostar Pharmaceuticals files for non-timely 10-Q with U.S. SEC
Wednesday, 17 Aug 2016 

Biostar Pharmaceuticals Inc : Files for non-timely 10-Q with U.S. SEC - SEC filing .Says expects that quarterly report that is subject hereof will be filed within the time frame allowed by the extension.  Full Article

Biostar Pharma Q1 sales fall 88.4 pct to $800,000
Tuesday, 24 May 2016 

Biostar Pharmaceuticals Inc : Biostar Pharmaceuticals, Inc. Announces its quarterly results for three months ended march 31, 2016 .Q1 sales fell 88.4 percent to $800,000.  Full Article

BRIEF-Biostar Pharma qtrly ‍loss per share $0.05

* Biostar Pharmaceuticals Inc. announces its quarterly results for nine months ended September 30, 2017